Ziopharm Oncology reported $24.32M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US $ 36522M 332M
AstraZeneca AZN:LN 29528M 1571M
Baxter International BAX:US $ 16686M 488M
Biogen BIIB:US $ 7277.2M 2M
Bioline Rx BLRX:US $ 3.71M 0.94M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Corcept Therapeutics CORT:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0M 0M
GlaxoSmithKline GSK:LN 22111M 11217M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intrexon XON:US $ 198.67M 2.79M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Novartis NOVN:VX SF 31031M 244M
Ptc Therapeutics PTCT:US $ 1207.54M 10.46M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Verastem VSTM:US $ 24.54M 0.13M
YTE INCY:US $ 34.19M 0.01M
Ziopharm Oncology ZIOP:US $ 24.32M 0.2M